Skip to main content

Table 2 Sensitivity and specificity of the DBMA-Fv in relation to chart review at T2

From: Validation of the disease burden morbidity assessment by self-report in a French-speaking population

Disease

TP + FN*

TP

Sensitivity %

CI 95%*

TN + FP*

TN

Specificity %

CI 95%

Prevalence % (n) †

Hypertension

26

20

77.0

56.4 - 91.0

57

55

96.5

87.9 - 99.6

31.3 (83)

Elevated cholesterol

32

26

81.2

63.6 - 92.8

52

50

96.2

86.8 - 99.5

38.1 (84)

Asthma

10

9

90.0

55.5 - 99.7

74

71

95.9

88.6 - 99.2

11.9 (84)

Diabetes

12

9

75.0

42.8 - 94.5

72

71

98.6

92.5 - 100

14.3 (84)

Osteoarthritis

21

14

66.7

43.0 - 85.4

63

55

87.3

76.5 - 94.4

25.0 (84)

Rheumatic disease, other

22

15

68.2

45.1 - 86.1

62

56

90.3

80.1 - 96.4

26.2 (84)

Overweight

16

12

75.0

47.6 - 92.7

67

52

77.6

65.8 - 86.9

19.3 (83)

Angina/coronary artery disease

16

10

62.5

35.4 - 84.8

67

65

97.0

89.6 - 99.6

19.3 (83)

Depression/Anxiety

13

9

69.2

38.6 - 90.9

71

64

90.1

80.7 - 95.9

15.5 (84)

  1. * TP = True Positive; FN = False Negative; TN = True Negative; FP = False Positive; CI 95% = 95% Confidence Interval.
  2. † Total n = 84 (one chart could not be retrieved). Differences between the total n and the actual n used in calculations in some diseases are due to incomplete data in the questionnaires that were not considered in the calculation.